Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Pisano, Marina ^a   Pagnan, Gabriella ^b   Loi, Monica ^a   Mura, Maria Elena ^a   Tilocca, Maria Giovanna ^a   Palmieri, Giuseppe ^a   Fabbri, Davide ^a   Dettori, Maria Antonietta ^a   Delogu, Giovanna ^a   Ponzoni, Mirco ^b   Rozzo, Carla ^a  

^a CNR   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6,6' DIBROMODEHYDRODIEUGENOL; BIPHENYL; BIPHENYL DERIVATIVE; CASPASE; CISPLATIN; DEHYDRODIEUGENOL; ETOPOSIDE; EUGENOL; ISOEUGENOL; METHYLEUGENOL; METHYLISOEUGENOL; MONOMER; O,O' DIMETHYLDEHYDRODIEUGENOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENANTIOMER; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VIVO STUDY; MELANOMA; NEUROECTODERM TUMOR; RACEMIC MIXTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELL PROLIFERATION; DIMERIZATION; EUGENOL; HUMANS; IN SITU NICK-END LABELING; INHIBITORY CONCENTRATION 50; MELANOMA; SKIN NEOPLASMS; TIME FACTORS;

EID: 33846994046     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-8     Document Type: Article

References (40)

1. Bataille V Genetic epidemiology of melanoma Eur J Cancer 2003 39 1341-1347 10.1016/S0959-8049(03)00313-7 12826035
2. Chin L The genetics of malignant melanoma: Lessons from mouse and man Nat Rev Cancer 2003 3 8 559-570 10.1038/nrc1145 12894244
3. Armstrong BK Kricker A The epidemiology of UV induced skin cancer J Photochem Photobiol B 2001 63 8-18 10.1016/S1011-1344(01)00198-1 11684447
4. Margolin KA Biochemotherapy for melanoma: Rational therapeutics in the search for weapons of melanoma destruction Cancer 2004 101 435-438 10.1002/cncr.20402 15274056
5. Sondak VK Sabel MS Mule JJ Allogeneic and autologous melanoma vaccines: where have we been and where are we going? Clin Cancer Res 2006 12 2337s-2341s 10.1158/1078-0432.CCR-05-2555 16609055
6. Balch CM Soong SJ Gershenwald JE Thompson JF Reintgen DS Cascinelli N Urist M McMasters KM Ross MI Kirkwood JM Atkins MB Thompson JA Coit DG Byrd D Desmond R Zhang Y Liu PY Lyman GH Morabito A Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 2001 19 3622-3634 11504744
7. Dorai T Aggarwal BB Role of chemopreventive agents in cancer therapy Cancer Letters 2004 215 129-140 10.1016/j.canlet.2004.07.013 15488631
8. Rasheed A Laekeman G Totte J Vietinch AJ Herman AG Eugenol and prostaglandin biosynthesis New Engl J Med 1984 310 50-51 6689743
9. Burt S Essential oils: Their antibacterial properties and potential applications in foods-a review Int J Food Microbiol 2004 94 223-253 10.1016/j.ijfoodmicro.2004.03.022 15246235
10. Miller JA Swanson AB Miller EC The metabolic activation of safrole and related naturally occurring alkenylbenzenes in relation to carcinogenesis by the compound Naturally occurring carcinogens-mutagens and modulators of carcinogenesis Tokyo: Japan Sci. Soc. Press/Baltimore: Univ. Park Press Miller EC, Miller JA, Hirono I, Sugimura T, Takayama S 1979 111-125
11. Stich HF Stich W Lam PP Potentiation of genotoxicity by concurrent application of compounds found in betel quid: Arecoline, eugenol, quercetin, chlorogenic acid and Mn2+ Mutat Res 1981 90 355-363 10.1016/ 0165-1218(81)90058-6 7335107
12. Benencia F Courreges MC In vitro and in vivo activity of eugenol on human herpesvirus Phytother Res 2000 14 495-500 10.1002/ 1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8 11054837
13. Park BS Song YS Yee SB Lee BG Seo SY Park YC Kim JM Kim HM Yoo YH Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis Apoptosis 2005 10 193-200 10.1007/s10495-005-6074-7 15711935
14. Ghosh R Nadiminty L Fitzpatrick JE Alworth WL Slaga TJ Kumar AP Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity J Biol Chem 2005 280 5812-5819 10.1074/ jbc.M411429200 15574415
15. Okada N Hirata A Murakami Y Shoji M Sakagami H Fujisawa S Induction of cytotoxicity and apoptosis and inhibition of cyclooxigenase-2 gene expression by eugenol-related compounds Anticancer Res 2005 25 3263-3270 16101137
16. Ogata M Hoshi M Urano S Endo T Antioxidant activity of eugenol and related monomeric and dimeric compounds Chem Pharm Bull 2000 48 1467-1469 11045452
17. Fujisawa S Atsumi T Kadoma Y Sakagami H Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity Toxicology 2002 177 39-54 10.1016/S0300-483X(02)00194-4 12126794
18. Saito M Sakagami H Fujisawa S Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) Anticancer Res 2003 23 4693-4701 14981915
19. Lo YC Teng CM Chen CF Chen CC Hong CY Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation Biochem Pharmacol 1994 47 549-553 10.1016/ 0006-2952(94)90187-2 8117323
20. Nakazawa T Yasuda T Ohsawa K Metabolites of orally administered Magnolia officinalis exstract in rats and man and its antidepressant-like effects in mice J Pharm Pharmacol 2003 55 1583-1591 10.1211/0022357022188 14713371
21. Bai X Cerimele F Ushio-Fukai M Waqas M Campbell PM Govindarajan B Der CJ Battle T Frank DA Ye K Murad E Dubiel W Soff G Arbiser JL Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumour growth in vivo J Biol Chem 2003 278 35501-35507 10.1074/ jbc.M302967200 12816951
22. Battle TE Arbiser J Frank DA The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells Blood 2005 106 690-697 10.1182/blood-2004-11-4273 15802533
23. Thornberry NA Caspases: Key mediators of apoptosis Chem Biol 1998 5 R97-103 10.1016/S1074-5521(98)90615-9 9578633
24. Delogu G Fabbri D Dettori MA Forni A Casalone G Enantiopure
25. Peana AT Chessa G Carta G Delogu G Fabbri D Eugenol, bis-eugenol and synthesized related-dimer compounds produce antinociception in the acetic acid-induced-writhing responses Curr Topics Phytochem 2004 6 137-143
26. Lednicer D Strategies for organic drug synthesis and design New York, NY: John Wiley and Sons, Inc 1998
27. Fujihashi T Hara H Sakata T Mori K Higuchi H Tanaka A Kaji H Kaji A Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase Antimicrob Agents Chemother 1995 39 2000-2007 162871 8540706
28. Chen DF Zhang S Xie L Xie JX Chen K Kashiwada Y Zhou BN Wang P Cosentino LM Lee KH Anti AIDS agents - XXVI. Structure-activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues Bioorg Med Chem 1997 5 1715-1723 10.1016/ S0968-0896(97)00118-1 9313872
29. Brignole C Marimpietri D Pastorino F Nico B Di Paolo D Cioni M Piccardi F Cilli M Pezzolo A Corrias MV Pistoia V Ribatti D Pagnan G Ponzoni M Effect of Bortezomib on Human Neuroblastoma Cell Growth, Apoptosis, and Angiogenesis J Natl Cancer Inst 2006 98 1142-1157 16912267
30. Brown JM Attardi LD The role of apoptosis in cancer development and treatment response Nat Rev Cancer 2005 5 231-237 10.1038/nrc1560 15738985
31. Kroemer G Martin SJ Caspase-independent cell death Nat Med 2005 11 725-730 10.1038/nm1263 16015365
32. Abdel-Malek ZA Swope VB Nordlund JJ Medrano EE Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site Pigment Cell Res 1994 7 116-122 10.1111/ j.1600-0749.1994.tb00035.x 8066017
33. Montaldo PG Pagnan G Pastorino F Chiesa V Raffaghello L Kirchmeier M Allen TM Ponzoni M N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death Int J Cancer 1999 81 262-267 10.1002/ (SICI)1097-0215(19990412)81:2<262::AID-IJC16>3.0.CO;2-A 10188729
34. Cornaglia-Ferraris P Sansone R Mariottini GL Longo L Tonini GP Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line Int J Cancer 1990 45 578-579 2307545
35. Seeger RC Rayner SA Banerjee A Chung H Laug WE Neustein HB Benedict WF Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines Cancer Res 1977 37 1364-1371 856461
36. Ponzoni M Bocca P Chiesa V Decensi A Pistoia V Raffaghello L Rozzo C Montaldo PG Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: Apoptosis versus differentiation Cancer Res 1995 55 853 861 7850799
37. Pagnan G Montaldo PG Pastorino F Raffaghello L Kirchmeier M Allen TM Ponzoni M GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide Int J Cancer 1999 81 268-274 10.1002/ (SICI)1097-0215(19990412)81:2<268::AID-IJC17>3.0.CO;2-1 10188730
38. Kueng W Silber E Eppenberger U Quantification of Cells Cultured on 96-Well Plates Anal Biochem 1989 182 16-19 10.1016/0003-2697(89)90710-0 2604040
39. Keshelava N Tsao-Wei D Reynolds CP Pyrazoloacridine is active in multidrugresistant neuroblastoma cell lines with nonfunctional p53 Clin Cancer Res 2003 9 3492-3502 12960142
40. Marimpietri D Nico B Vacca A Mangieri D Catarsi P Ponzoni M Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin Oncogene 2005 24 6785-6795 10.1038/sj.onc.1208829 16007159